Appropriateness of statins in patients aged ≥80 years and comparison to other age groups

American Journal of Cardiology

Volumn 110, Issue 10, 2012, Pages 1477-1481

  Chokshi, Neel P ^a,b   Messerli, Franz H ^a   Sutin, David ^b   Supariwala, Azhar A ^a   Shah, Nirav R ^b,c,d  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEISINGER MEDICAL CENTER   (United States)

^d NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; COMORBIDITY; CORONARY ARTERY DISEASE; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; DRUG UTILIZATION; ELECTRONIC MEDICAL RECORD; FEMALE; GERIATRIC PATIENT; GROUPS BY AGE; HUMAN; HYPERLIPIDEMIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PERIPHERAL VASCULAR DISEASE; PRESCRIPTION; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGE FACTORS; AGED; AGED, 80 AND OVER; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PENNSYLVANIA; PRIMARY PREVENTION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84868207719     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.06.058     Document Type: Article

References (14)

1. W. He, M. Sengupta, V.A. Velko, K.A. DeBarros Current population reports, P23-209, 65+ in the United States: 2005 In: Bureau USC, ed. 2005 U.S. Government Printing Office Washington DC
2. D.M. Qato, G.C. Alexander, R.M. Conti, M. Johnson, P. Schumm, S.T. Lindau Use of prescription and over-the-counter medications and dietary supplements among older adults in the United States JAMA 300 2008 2867 2878
3. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Third report of the national cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment Panel III) final report Circulation 106 2002 3143 3421
4. M.E. Charlson, P. Pompei, K.L. Ales, C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chronic Dis 40 1987 373 383 (Pubitemid 17055592)
5. W.H. Hall, R. Ramachandran, S. Narayan, A.B. Jani, S. Vijayakumar An electronic application for rapidly calculating Charlson comorbidity score BMC Cancer 4 2004 94
6. G. Trifirò, M. Alacqua, S. Corrao, M. Tari, V. Arcoraci Statins for the primary prevention of cardiovascular events in elderly patients: a picture from clinical practice without strong evidence from clinical trials J Am Geriatr Soc 56 2008 175 177
7. D.T. Ko, M. Mamdani, D.A. Alter Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox JAMA 291 2004 1864 1870 (Pubitemid 38509499)
8. L.K. Petersen, K. Christensen, J. Kragstrup Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds Aging 39 2010 674 680
9. I.J. Schatz, K. Masaki, K. Yano, R. Chen, B.L. Rodriguez, J.D. Curb Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study Lancet 358 2001 351 355 (Pubitemid 32739094)
10. R.S. Newson, J.F. Felix, J. Heeringa, A. Hofman, J.C. Witteman, H. Tiemeier Association between serum cholesterol and noncardiovascular mortality in older age J Am Geriatr Soc 59 2011 1779 1785
11. J. Shepherd, G.J. Blauw, M.B. Murphy, E.L. Bollen, B.M. Buckley, S.M. Cobbe, I. Ford, A. Gaw, M. Hyland, J.W. Jukema, A.M. Kamper, P.W. Macfarlane, A.E. Meinders, J. Norrie, C.J. Packard, I.J. Perry, D.J. Stott, B.J. Sweeney, C. Twomey, R.G. Westendorp PROSPER Study Group (PROspective Study of Pravastatin in the Elderly at Risk) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial Lancet 360 2002 1623 1630 (Pubitemid 35379733)
12. J. Afilalo, G. Duque, R. Steele, J.W. Jukema, A.J. de Craen, M.J. Eisenberg Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis J Am Coll Cardiol 51 2008 37 45
13. W. de Ruijter, R.G. Westendorp, W.J. Assendelft, W.P. den Elzen, A.J. de Craen, S. le Cessie, J. Gussekloo Use of Framingham risk score and new biomarkers to predict cardiovascular mortality in older people: population based observational cohort study BMJ 338 2009 a3083
14. P. Hsiao, G.C. Wood, T. Hartman, C. Still, G. Jensen PS1-19: using electronic data extraction to identify subjects with metabolic syndrome: a validation using manual chart review Clin Med Res 9 2011 168